Oasmia announces launch of private placement of new shares

Oasmia Pharmaceutical AB (publ) (“Oasmia” or the “Company”) announces the launch of a private placement of new shares through a directed new share issue.

Oasmia has retained Carnegie Investment Bank as placing agent in a private placement of new shares (the “New Shares”) directed towards qualified investors in Sweden (the "Private Placement").

The Private Placement will be carried out with deviation from the shareholders’ preferential rights and in accordance with the AGM’s resolution, on September 30, 2011, to authorize the Board of Directors in Oasmia to, at one or several occasions until the next AGM, issue new shares.

Pricing and allocation of the Private Placement is expected to take place before beginning of trading on NASDAQ OMX Stockholm at 09:00 am CET on October 25, 2011.

The proceeds from the Private Placement will strengthen Oasmia’s financial position for the continued clinical development of its product portfolio and improve the Company’s position in ongoing and upcoming discussions with existing and potential new sales partners.